Thus, acute treatment may be insufficient to provide clinical improvements in ApoE 4 carriers, with long-lasting stimulation necessary to observe functional benefits [151]
The one consequence to be drawn from these considerations is not to treat subjects at high risk for developing medullary thyroid carcinoma based on multiple endocrine neoplasia or familial medullary thyroid carcinoma with liraglutide (according the label), and it is advisable to practice caution with other incretin-based medications as well
Grieco M, Giorgi A, Gentile MC, dErme M, Morano S, Maras B, et al
Diabetes Care (2014) 37:216876
The goal is to support appetite, cravings, and metabolic behavior while reducing the chance that side effects interrupt treatment
Berberine and Ozempic both influence metabolism, but they work differently and to very different degrees